November 9, 2007 - The National Mammography Quality Assurance Advisory Committee advised that the FDA lift the current exemption of stereotactic breast biopsy from the MQSA regulations at a meeting held Nov. 5.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now